InNexus Biotechnology Announces an Expansion of its SuperAntibody R&D Program
InNexus Biotechnology Inc. announced the extension and expansion of its research and development program for SuperAntibody Technology (SAT) by expanding its R&D facilities within the Kentucky Technology Center on the Coldstream Research Campus in Lexington, Kentucky. This modern laboratory facility includes equipment for fluorescence flow cytometry analysis (FACS), ELISA, a full protein chemistry lab, cell culturing and other infrastructure.
The expansion is being made to accommodate more partnerships, expanded R&D activities, and scale-up of its product development program to advance development of InNexus' leading drug candidate, SuperAntibody(TM) T15, a treatment for reduction of plaque in coronary artery disease. InNexus is focused on maximizing the value of its two technology platforms, SuperAntibody(TM) and TranMAbs(TM), for empowering monoclonal antibodies.
Commenting on the announcement, Dr. Charles Morgan, the President of InNexus, said: "This expansion further validates our commitment to our partners for providing resources and capacity for SuperAntibody development. Interest in our SAT platform has outstripped our previous resources and the new facility increases our ability to enter into partnerships by increasing our ability to provide R&D feasibility studies and generate the data required for the development projects of our partners".
Other news from the department manufacturing
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.